Literature DB >> 15789789

Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases.

A Mandal1, J Watson.   

Abstract

BACKGROUND: Hidradenitis suppuritiva, a disease of the apocrine sweat glands, has always been a challenging area to the plastic and reconstructive surgeon. The aetiology is idiopathic and medical treatment offers temporary relief only. Radical surgical excision, therefore, is the mainstay of active management. AIM: To present and evaluate a series of 106 patients of hidradenitis suppuritiva treated in the regional plastic surgery unit of southeast Scotland between January 1990 and December 2000. PATIENTS: Median age at onset was 36 years (range 17-70 years). The patients were predominantly females (88.78%) and heavy smokers (98.1%). Median age before active surgical intervention was six years (range 1-30 years). The patients were divided into a mild group (n=64) and a severe group (n = 42). All patients had broad-spectrum antibiotics and multiple incision and drainage procedures before referral from general practitioners, dermatologists or general surgeons. One hundred sites were managed by primary closure (mostly in the 'mild' group); 29 resurfaced with split skin grafts and 14 with local, fasciocutaneous or musculocutaneous flaps (mostly in the 'severe' group). Median postoperative follow-up period was three years (range 1-7 years).
RESULTS: In the 'primary closure' series, recurrence rate requiring at least one secondary operation was 69.88%. There was no recurrence, no serious complications and no revision operations in the 'graft' and the 'flap' series.
CONCLUSION: A high index of suspicion is required before contemplating primary closure in hidradenitis suppuritiva, even in the ' mild' variety. This condition should always be treated aggressively by radical excision of all hair-bearing areas and reconstructed with a graft or a flap.

Entities:  

Mesh:

Year:  2005        PMID: 15789789     DOI: 10.1016/s1479-666x(05)80006-x

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  21 in total

Review 1.  [Surgical management of acne inversa].

Authors:  G Weyandt
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

2.  Extensive groin and perineal hidradenitis suppurativa complicated by high fistula in ano.

Authors:  Hk Aduful; A Paintsil
Journal:  Ghana Med J       Date:  2007-03

3.  [Acne inversa].

Authors:  F G Bechara; W Hartschuh
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

4.  The surgeon’s perspective: a retrospective study of wide local excisions taken to healthy subcutaneous fat in the management of advanced hidradenitis suppurativa

Authors:  Eran Shavit; Andrew Pawliwec; Afsaneh Alavi; Ralph George
Journal:  Can J Surg       Date:  2020-02-28       Impact factor: 2.089

5.  Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix.

Authors:  Fabio Nicoli; Alberto Balzani; Davide Lazzeri; Pietro Gentile; Ram M Chilgar; Camilla Di Pasquali; Marzia Nicoli; Ilaria Bocchini; Annarita Agovino; Valerio Cervelli
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

Review 6.  [Surgical treatment options for hidradenitis suppurativa/acne inversa].

Authors:  L Scholl; S Hessam; S Reitenbach; F G Bechara
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

7.  Factors influencing the local cure rate of hidradenitis suppurativa following wide local excision.

Authors:  Ledibabari M Ngaage; Yinglun Wu; Shealinna Ge; Selim Gebran; Fan Liang; Erin M Rada; Arthur J Nam; Ronald P Silverman; Yvonne M Rasko
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

Review 8.  Pain Control in Dermatologic Conditions.

Authors:  Vijay Kodumudi; David Lam; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

Review 9.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

10.  Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa.

Authors:  Michael V DeFazio; James M Economides; Kathryn S King; Kevin D Han; Victoria K Shanmugam; Christopher E Attinger; Karen K Evans
Journal:  Ann Plast Surg       Date:  2016-08       Impact factor: 1.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.